Impact of Adding the Multikinase Inhibitor Sorafenib to Endocrine Therapy in Metastatic Estrogen Receptor-Positive Breast Cancer

Future Oncology - United Kingdom
doi 10.2217/fon.14.99
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer

JAMA Oncology
Cancer ResearchOncology
2016English

Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers

Frontiers in Oncology
Cancer ResearchOncology
2017English

Extracellular Alkaline pH Leads to Increased Metastatic Potential of Estrogen Receptor Silenced Endocrine Resistant Breast Cancer Cells

PLoS ONE
Multidisciplinary
2013English

Phosphatidyl-Inositol-3-Kinase Alpha Catalytic Subunit Mutation and Response to Neoadjuvant Endocrine Therapy for Estrogen Receptor Positive Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2009English

Oral Selective Estrogen Receptor Downregulators (SERDs), a Breakthrough Endocrine Therapy for Breast Cancer

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2018English

New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies

Clinical Cancer Research
Cancer ResearchOncology
2016English

Addition of Everolimus and Trastuzumab to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2019English

Endocrinology and Hormone Therapy in Breast Cancer: New Insight Into Estrogen Receptor-Α Function and Its Implication for Endocrine Therapy Resistance in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy